GLP1R and obesity due to melanocortin 4 receptor deficiency: The application of GLP-1 RAs in type 1 diabetes exemplifies precision medicine addressing specific patient phenotypes, with concomitant obesity common among patients and only 20% achieving adequate glycemic control.